v3.26.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operations:    
Net loss $ (9,275,577) $ (9,052,128)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation and amortization 1,240,273 1,007,817
Amortization of debt discount 278,499 278,499
Non-cash equity-based compensation expense 3,097,885 3,041,157
Equity-based payment of interest 363,039
Change in operating assets and liabilities    
Inventory 951,887 105,050
Accounts receivable (42,264) (396,008)
Prepaid expenses and other assets (75,838) (782,169)
Deferred revenues (521,468) 398,599
Operating lease liabilities (629,292) (564,922)
Royalty obligation (125,000)
Accounts payable and accrued expenses (1,276,176) 1,639,430
Net cash used in operating activities (6,014,032) (4,324,675)
Investing:    
Purchase of property and equipment (93,979) (413,365)
Net cash used in investing activities (93,979) (413,365)
Financing:    
Proceeds from issuance of common stock - offerings 27,423,760 459,634
Placement cost (31,756) (9,206)
Dividends paid (249,111) (212,668)
Proceeds from  exercise of warrants and options 1,911,101
Principal repayments of notes payable (734,864) (121,908)
Net cash provided by financing activities 28,319,130 1,540,852
Change in cash and cash equivalents, and restricted cash 22,211,119 (3,197,188)
Cash, cash equivalents and restricted cash at beginning of the period 10,102,621 15,500,495
Cash, cash equivalents and restricted cash at end of period 32,313,740 12,303,307
Supplementary disclosure of non-cash financing activities:    
Fair value of shares to satisfy obligations under convertible notes 363,039
Accrued dividends payable 8,044
Cash paid during the period for:    
Interest 1,113,417 1,378,223
Taxes
Nonrelated Party [Member]    
Financing:    
Proceeds from issuance of preferred stocks $ 1,425,000